Search Results 621-630 of 18241 for Immunode

1. A Study Evaluating the Safety, Tolerability, Preliminary Drug/Body Interactions and Biological Activity of MYK-461 - Mayo Clinic

   History of positive human immunodeficiency virus (HIV) test and/or seropositive for hepatitis C virus (HCV) or hepatitis B virus (HBV). Participating Mayo ...

2. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   Known history of positive test for human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (testing at Screening is not required). If ...

3. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Subject with known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, or known active or chronic hepatitis B or C ...

4. A Study to Determine the Effectiveness and Safety of Benralizumab for Patients with Severe Nasal Polyposis - Mayo Clinic

   History of known immunodeficiency disorder, including a positive human immunodeficiency virus (HIV) test. Infection requiring systemic antibiotics (Ab) ...

5. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   Known positivity for human immunodeficiency virus infection. Subjects with recent history (within 1 year of Day 1) of significant atherosclerotic ...

6. Study in Pediatrics with HypEREosinophilic Syndrome - Mayo Clinic

   Participants with a known immunodeficiency (e.g., Human immunodeficiency virus [HIV]), other than that explained by the use of OCS or other therapy taken for ...

7. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

   Serologic evidence of human immunodeficiency 1 or 2 infection; Epstein Barr Virus (EBV) seronegativity (EBV naïve) if living donor is EBV seropositive ...

8. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

   In order for patients with human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS) to be eligible, they must be on a stable ...

9. A Study to Assess the Effectiveness, Safety, and Tolerability of Brensocatib in Participants with Non-Cystic Fibrosis Bronchiectasis (ASPEN) - Mayo Clinic

   Current smokers as defined per Centers for Disease Control (CDC). 4. Known or suspected immunodeficiency disorder, including history of invasive

10. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    Positive for human immunodeficiency virus (HIV) or hepatitis B or C; Receipt of a live virus vaccine within 28 days prior to Day 1 of Cycle 1; Poor ...